³Ô¹ÏÍøÕ¾

Latest

Latest oncology News | Page 3

  • Latest oncology news stories and updates. What is happening today? All recent oncology news and developments. Live coverage and timeline of oncology. All you need to know about oncology.
Research uses AI to improve outcomes for brain cancer patients
Botswana-Baylor pediatric HIV/AIDS program: The impact 20 years later
Imagion Biosystems announces appointment of new CEO
Datopotamab deruxtecan combinations showed encouraging tumour responses in patients with advanced non-small cell lung cancer in TROPION-Lung02 Phase Ib trial
Enhertu demonstrated clinically meaningful and durable responses in patients across multiple HER2-expressing advanced solid tumours
Tagrisso achieved unprecedented survival in early-stage EGFR-mutated lung cancer, with 88% of patients alive at five years in ADAURA Phase III trial
Lynparza and Imfinzi combination reduced risk of disease progression or death by 37% vs. chemotherapy and bevacizumab in patients with advanced ovarian…
Update on brazikumab development programme
Chimeric Therapeutics announces new trial for CHM 1101 in glioblastoma
Ludwig Chicago study identifies potentially new strategy for combination radio- and immunotherapy
KAZIA CEO, DR JOHN FRIEND PARTICIPATES IN WHITE HOUSE CANCER MOONSHOT FORUM Brain Cancers Forum on Glioblastoma & Diffuse Intrinsic Pontine Glioma Forum
1 week to go – save date
Oncosil Medical announces first patient treatment in Italy
Mater launches trial of Australian-first flu vaccine
Positive results for Immutep’s cancer candidate in combination with MSD’s Keytruda
When facing ovarian cancer, Susan Catton saw an opportunity to help others
Mater Research leads in palliative care oncology research
Mater Research Celebrates International Nurses Day
LBT Innovations begins search for new board chair
Chance to lift lung cancer survival
Carina Biotech to present details of planned trial of CAR-T cell therapy candidate
Monash Expert: When it comes to cancer care, your postcode should not matter
Lynparza and Imfinzi combination improved progression-free survival in newly diagnosed patients with advanced ovarian cancer without tumour BRCA mutations in DUO-O Phase III trial
Radiopharm Theranostics and GenesisCare partner on development of radiopharmaceutical
Denise and Graeme’s Love and support throughout their cancer experience
Antibody fragment-nanoparticle therapeutic eradicates cancer
Interim analysis shows accuracy of Optiscan Imaging platform
FDA grants ‘orphan’ designation to PTX-100 for broader TCL indications
Compassionate women in the driver’s seat helping vulnerable patients
Compassionate women in driver’s seat helping patients
Starpharma announces appointment of chief financial officer
Warrnambool is the next stop on Breast Cancer Network Australia’s tour of regional Australia
Enhertu showed clinically meaningful and durable responses across multiple HER2-expressing tumour types in DESTINY-PanTumor02 Phase II trial
Differences in animal biology can affect cancer drug development
Greenslopes Private Hospital offers new program to treat cancer at home
Radiotherapy optional for older breast cancer patients
AusBiotech develops first biotech ESG guidance
Study aims to cut pain and enhance chemo for ovarian cancer patients
Datopotamab deruxtecan showed promising responses as monotherapy and in combination with Imfinzi
Datopotamab deruxtecan showed encouraging and durable efficacy in patients with heavily pretreated HR-positive
Camizestrant significantly delayed disease progression in advanced ER-positive breast cancer
Capivasertib plus Faslodex reduced risk of disease progression or death by 40% versus Faslodex
Enhertu achieved statistically significant overall survival, reducing risk of death by 36% vs. trastuzumab emtansine
Noxopharm provides update on trial of its oncology drug candidate
AstraZeneca aims to redefine breast cancer care with new data across treatment spectrum at SABCS 2022
Allens advises IFM Investors on buyout of PRP Diagnostic Imaging
International Gynecologic Cancer Society expands gynecologic oncology fellowships for improved access to cervical cancer treatment
Telix announces positive topline results of late-stage imaging study

© 2024 - ³Ô¹ÏÍøÕ¾